The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.

News Articles

The ISSCR applauds the decision announced today by the U.S. District Court for the District of Columbia in the case of Sherley v. Sebelius, dismissing challenges to the U.S. National Institutes of Health’s (NIH’s) funding of human embryonic stem cell research.

The ISSCR announced today that it has launched "A Closer Look at Stem Cell Treatments" (www.closerlookatstemcells.org), a Web site to arm patients, their families and doctors with information they need to make decisions about stem cell treatments

In the interest of improving world health we urge the NIH to open discussions on funding research carried out with human pluripotent stem cell lines derived from sources other than excess reproductive IVF embryos, including SCNT embryos, if they become available and are derived under rigorous ethical standards.

The ISSCR congratulates two board members who were named recipients of two of the nation’s top science awards, Shinya Yamanaka, MD, PhD (Kyoto University), and Elaine Fuchs, PhD (Rockefeller University).

The ISSCR is concerned and saddened by the recent report of nervous system tumors that developed in a child who had previously received injections of cell preparations referred to as “neural stem cells.” This illustrates the concerns that prompted the ISSCR to develop Guidelines for the Clinical Translation of Stem Cells, released in December 2008.

The ISSCR applauds President Barack Obama’s decision to expand federal funding for human embryonic stem cell research by rescinding the policy of Aug. 9, 2001, which restricted federally-funded researchers to using only the small number of cell lines created before that date.

The ISSCR shares in the excitement generated by the U.S. Food and Drug Administration‘s landmark decision to approve the first clinical trials using the products of human embryonic stem cells, yet advises the public to maintain realistic expectations at this early stage.

The ISSCR releases Guidelines for the Clinical Translation of Stem Cells, defining a roadmap for medical researchers and doctors, outlining what needs to be accomplished to move stem cells from promising research to proven treatments for patients

In a ceremony today ISSCR President-Elect Irving L. Weissman (USA), Board Member Shinya Yamanaka (Japan) and Member Hans Schöler (Germany) were awarded the prestigious Robert Koch Prize by the Robert Koch Foundation. The International Society for Stem Cell Research congratulates them for earning this honor.

The ISSCR, representing the world’s leading stem cell scientists, urges President-Elect Barack Obama to restore federal funding for embryonic stem cell research in the first 100 days of his presidency.

On Tuesday, Michigan voters were asked to support Michigan’s Proposal 2, a state initiative to accelerate medical research and develop new stem cell treatments for currently incurable diseases. The International Society for Stem Cell Research (ISSCR), representing some of the world’s leading stem cell researchers, along with other leading scientists works to support all types of stem cell research. The vote was 53% in favor and 47% opposed to Proposal 2.